OBJECTIVE: Large body size has been associated with decreased risk of breast cancer in premenopausal women but with increased risk in postmenopausal women. Limited information is available about African-American women and differences by estrogen and progesterone receptor status. METHODS: We analyzed data from the Women's Contraceptive and Reproductive Experiences Study among 3,997 white and African-American breast cancer case patients diagnosed in 1994 to 1998 and 4,041 control participants ages 35 to 64 years. We calculated multivariate odds ratios (OR) as measures of relative risk of breast cancer associated with self-reported body mass index (BMI) at age 18 and 5 years before diagnosis (recent BMI). RESULTS: Risk tended to decrease with increasing BMI at age 18 years in all women [OR(BMI > or = 25 kg/m(2) versus < 20 kg/m(2)) = 0.76; 95% confidence interval (CI), 0.63-0.90; P(trend) = 0.005] and with recent BMI in premenopausal women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 0.81; 95% CI, 0.61-1.06; P(trend) = 0.05), unmodified by race. Among postmenopausal white but not African-American women, there was an inverse relation between recent BMI and risk. High recent BMI was associated with increased risk of estrogen receptor- and progesterone receptor-positive tumors among postmenopausal African-American women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 1.83; 95% CI, 1.08-3.09; P(trend) = 0.03). CONCLUSION: Among women at age 35 to 64 years, BMI at age 18 years is inversely associated with risk of breast cancer, but association with recent BMI varies by menopause status, race, and hormone receptor status. IMPACT: Our findings indicate that studies of BMI and breast cancer should consider breast cancer subtypes. Copyright 2010 AACR.
OBJECTIVE: Large body size has been associated with decreased risk of breast cancer in premenopausal women but with increased risk in postmenopausal women. Limited information is available about African-American women and differences by estrogen and progesterone receptor status. METHODS: We analyzed data from the Women's Contraceptive and Reproductive Experiences Study among 3,997 white and African-American breast cancer case patients diagnosed in 1994 to 1998 and 4,041 control participants ages 35 to 64 years. We calculated multivariate odds ratios (OR) as measures of relative risk of breast cancer associated with self-reported body mass index (BMI) at age 18 and 5 years before diagnosis (recent BMI). RESULTS: Risk tended to decrease with increasing BMI at age 18 years in all women [OR(BMI > or = 25 kg/m(2) versus < 20 kg/m(2)) = 0.76; 95% confidence interval (CI), 0.63-0.90; P(trend) = 0.005] and with recent BMI in premenopausal women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 0.81; 95% CI, 0.61-1.06; P(trend) = 0.05), unmodified by race. Among postmenopausal white but not African-American women, there was an inverse relation between recent BMI and risk. High recent BMI was associated with increased risk of estrogen receptor- and progesterone receptor-positive tumors among postmenopausal African-American women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 1.83; 95% CI, 1.08-3.09; P(trend) = 0.03). CONCLUSION: Among women at age 35 to 64 years, BMI at age 18 years is inversely associated with risk of breast cancer, but association with recent BMI varies by menopause status, race, and hormone receptor status. IMPACT: Our findings indicate that studies of BMI and breast cancer should consider breast cancer subtypes. Copyright 2010 AACR.
Authors: Daikwon Han; Jing Nie; Matthew R Bonner; Susan E McCann; Paola Muti; Maurizio Trevisan; Farah A Ramirez-Marrero; Dominica Vito; Jo L Freudenheim Journal: Int J Cancer Date: 2006-12-15 Impact factor: 7.396
Authors: A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson Journal: JAMA Date: 2006-07-12 Impact factor: 56.272
Authors: Martha L Slattery; Carol Sweeney; Sandra Edwards; Jennifer Herrick; Kathy Baumgartner; Roger Wolff; Maureen Murtaugh; Richard Baumgartner; Anna Giuliano; Tim Byers Journal: Breast Cancer Res Treat Date: 2007-03 Impact factor: 4.872
Authors: Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou Journal: Breast Cancer Res Treat Date: 2007-06-20 Impact factor: 4.872
Authors: Julie R Palmer; Lucile L Adams-Campbell; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-09 Impact factor: 4.254
Authors: Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark Journal: Cancer Prev Res (Phila) Date: 2012-02-07
Authors: Elisa V Bandera; Urmila Chandran; Gary Zirpoli; Gregory Ciupak; Dana H Bovbjerg; Lina Jandorf; Karen Pawlish; Jo L Freudenheim; Christine B Ambrosone Journal: Cancer Causes Control Date: 2013-10-10 Impact factor: 2.506
Authors: Shawna B Matthews; Zongjian Zhu; Weiqin Jiang; John N McGinley; Elizabeth S Neil; Henry J Thompson Journal: Cancer Prev Res (Phila) Date: 2014-01-17
Authors: Meera Sangaramoorthy; Amanda I Phipps; Pamela L Horn-Ross; Jocelyn Koo; Esther M John Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-11-04 Impact factor: 4.254